Biopol Chemicals SME IPO GMP History
Biopol Chemicals SME IPO has been listed on February 13, 2026 at a listing price of ₹111, against the issue price of ₹108 — a gain of ₹3 (+2.78%). The GMP peaked at ₹3 on 13 February 2026 and reached a low of ₹0 on 9 February 2026. The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Biopol Chemicals SME IPO raised ₹31 Cr. Cr. through its IPO at a price band of ₹102 to ₹108 per share, with a lot size of 1200 shares. The IPO was open for subscription from 06 Feb 2026 to 10 Feb 2026.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 25 Aug, 12:55 PM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| 13 Feb 2026 | ₹ 3 | — | 3% | — | ₹ 2700 |
| 12 Feb 2026 | ₹ 3 | — | 3% | — | ₹ 2700 |
| 11 Feb 2026 | ₹ 3 | — | 3% | — | ₹ 2700 |
| 10 Feb 2026 | ₹ 3 | ▲ | 3% | — | — |
| 09 Feb 2026 | ₹ 0 | — | -- | — | — |
| 07 Feb 2026 | ₹ 0 | — | -- | — | — |
| 06 Feb 2026 | ₹ 0 | — | -- | — | — |
| 05 Feb 2026 | ₹ 0 | — | -- | — | — |
| 04 Feb 2026 | ₹ 0 | — | -- | — | — |
| 03 Feb 2026 | ₹ 0 | — | -- | — | — |
| 02 Feb 2026 | ₹ 0 | — | -- | — | — |
| 01 Feb 2026 | ₹ 0 | — | -- | — | — |
| 31 Jan 2026 | ₹ 0 | — | -- | — | — |
| 30 Jan 2026 | ₹ 0 | — | -- | — | — |
| 29 Jan 2026 | ₹ 0 | — | -- | — | — |
| 28 Jan 2026 | ₹ 0 | — | -- | — | — |
| 27 Jan 2026 | ₹ 0 | — | -- | — | — |
Biopol Chemicals SME IPO dates
Key dates from opening to listing. Today is 3 October.
- Open 06 Feb 2026
- Close 10 Feb 2026
- Allotment 11 Feb 2026
- Refund/credit 12 Feb 2026
- Listing 13 Feb 2026
Biopol Chemicals SME IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹108 |
|---|---|
| GMP-based estimate (pre-listing) | ₹111 (+2.8%) |
| Listing gain / loss | +₹3 per share |
| Listing date | 13 Feb, 2026 |
| Actual listing price | ₹111 (+2.78%) |
Is Biopol Chemicals SME IPO GMP reliable?
Grey market premium for Biopol Chemicals SME IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Biopol Chemicals SME IPO full review for a fundamentals-based assessment before making any grey market trades.
Biopol Chemicals SME IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Biopol Chemicals SME IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was Retail: ₹2700. Unlike Kostak, Subject to Sauda only applies if you receive allotment.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Biopol Chemicals SME IPO
Biopol Chemicals was established with a vision to develop eco-friendly and sustainable chemical solutions, focusing on reducing environmental impact. Over the years, the company has built expertise in manufacturing specialty chemicals and biodegradable products used across industries such as agriculture, packaging, and consumer goods. Promoted by experienced professionals in the chemical sector, the company has gradually expanded its operations with a focus on innovation, quality, and compliance with environmental standards.
The company’s product portfolio includes bio-based chemicals, polymers, and additives designed to replace conventional synthetic materials. Its business model is centred on research-driven manufacturing and long-term client partnerships, catering to both domestic and international markets. By emphasising sustainability and cost-effective production, Biopol Chemicals aims to strengthen its position in the growing green chemicals segment while maintaining consistent operational efficiency.
Frequently asked
What is the GMP of Biopol Chemicals SME IPO?
The current Grey Market Premium (GMP) of Biopol Chemicals SME IPO is ₹ 3.
What is the Kostak Price of Biopol Chemicals SME IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Biopol Chemicals SME IPO is not available.
What is the Subject to Sauda Price of Biopol Chemicals SME IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is Retail: ₹2700.
What was the actual listing price of Biopol Chemicals SME IPO?
Biopol Chemicals SME IPO listed on February 13, 2026 at ₹111, against the issue price of ₹108 — a gain of +2.78%.
How did the GMP of Biopol Chemicals SME IPO trend before listing?
The GMP of Biopol Chemicals SME IPO was stable in its final days before listing. The GMP peaked at ₹3 on 13 February 2026. View the day-wise table above for the complete GMP history.
Explore Biopol Chemicals SME IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
